Doern G V, Tubert T
Department of Clinical Microbiology, University of Massachusetts Medical Center, Worcester 01605.
Antimicrob Agents Chemother. 1987 Oct;31(10):1519-23. doi: 10.1128/AAC.31.10.1519.
A total of 74 clinical isolates of Branhamella catarrhalis were characterized with respect to their ampicillin, amoxicillin-clavulanate, cephalothin, cefaclor, erythromycin, tetracycline, chloramphenicol, and trimethoprim-sulfamethoxazole MICs and zones of inhibition. Disk diffusion tests were performed according to the guidelines of the National Committee for Clinical Laboratory Standards with two different media (Mueller-Hinton agar and chocolate Mueller-Hinton agar) and plates incubated under two atmospheric conditions (ambient air and 5 to 7% CO2). Optimum disk diffusion test results were obtained with Mueller-Hinton agar plates incubated in ambient air with all eight antimicrobial agents. On the basis of comparisons of MICs versus zones of inhibition, the following zone diameter interpretive criteria were defined for testing B. catarrhalis with disks containing 10 micrograms of ampicillin: greater than or equal to 38 mm, susceptible; 20 to 37 mm, moderately susceptible; less than or equal to 19 mm, resistant. The respective MIC correlates were less than or equal to 0.06, 0.125 to 0.5, and greater than or equal to 1.0 micrograms/ml. Because of the absence of frankly resistant test organisms, it was not possible to make definitive recommendations pertaining to disk diffusion tests with amoxicillin-clavulanate, cephalothin, cefaclor, erythromycin, tetracycline, chloramphenicol, and trimethoprim-sulfamethoxazole. Evidence is presented, however, which suggests that the current National Committee for Clinical Laboratory Standards disk diffusion interpretive criteria for nonfastidious bacteria can be applied to B. catarrhalis, at least as they pertain to the susceptible category with cephalothin, amoxicillin-clavulanate, erythromycin, tetracycline, chloramphenicol, and trimethoprim-sulfamethoxazole. With cefaclor, a zone diameter of greater than or equal to 21 mm was determined to adequately define the susceptible category.
共对74株卡他布兰汉菌临床分离株进行了氨苄西林、阿莫西林-克拉维酸、头孢噻吩、头孢克洛、红霉素、四环素、氯霉素和甲氧苄啶-磺胺甲恶唑的最低抑菌浓度(MIC)及抑菌圈特征分析。按照美国国家临床实验室标准委员会的指南,使用两种不同培养基(穆勒-欣顿琼脂和巧克力穆勒-欣顿琼脂)并在两种大气条件(环境空气和5%至7%二氧化碳)下孵育平板进行纸片扩散试验。使用在环境空气中孵育的穆勒-欣顿琼脂平板对所有八种抗菌药物进行纸片扩散试验可获得最佳结果。基于MIC与抑菌圈的比较,针对用含10微克氨苄西林的纸片检测卡他布兰汉菌确定了以下抑菌圈直径解释标准:大于或等于38毫米,敏感;20至37毫米,中度敏感;小于或等于19毫米,耐药。各自的MIC相关性分别为小于或等于0.06、0.125至0.5以及大于或等于1.0微克/毫升。由于缺乏明显耐药的测试菌株,无法就阿莫西林-克拉维酸、头孢噻吩、头孢克洛、红霉素、四环素、氯霉素和甲氧苄啶-磺胺甲恶唑的纸片扩散试验给出明确建议。然而,有证据表明,美国国家临床实验室标准委员会目前针对非苛养菌的纸片扩散解释标准可应用于卡他布兰汉菌,至少在涉及头孢噻吩、阿莫西林-克拉维酸、红霉素、四环素、氯霉素和甲氧苄啶-磺胺甲恶唑的敏感类别方面如此。对于头孢克洛,确定抑菌圈直径大于或等于21毫米可充分界定敏感类别。